| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | dabrafenib | CTRPv2 | pan-cancer | AAC | 0.16 | 0.0009 |
| mRNA | AR-42 | GDSC1000 | pan-cancer | AAC | -0.1 | 0.001 |
| mRNA | decitabine | CTRPv2 | pan-cancer | AAC | -0.094 | 0.001 |
| mRNA | BRD-A02303741 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.002 |
| mRNA | CAY10603 | GDSC1000 | pan-cancer | AAC | -0.096 | 0.002 |
| mRNA | serdemetan | FIMM | pan-cancer | AAC | 0.44 | 0.002 |
| mRNA | CX-5461 | GDSC1000 | pan-cancer | AAC | -0.099 | 0.002 |
| mRNA | FTI-277 | GDSC1000 | pan-cancer | AAC | 0.1 | 0.002 |
| mRNA | GDC-0449 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.003 |
| mRNA | I-BET-762 | GDSC1000 | pan-cancer | AAC | -0.083 | 0.003 |